Natural H7N9 infection in humans boosts cross-group stalk-specific antibody responses broadly cross-reactive to heterosubtypic influenza hemagglutinins from both group 1 and group 2

Lu Liu(Shanghai Public Health Clinical Center), Jianqing Xu(Shanghai Medical College of Fudan University), Yang Bin Huang(Shanghai Medical College of Fudan University), Lingyan Zhu(Gannan Medical University), Anli Zhang(Southwestern Medical Center), Florian Krammer(Semmelweis University), Zhaoguang Dong(Shanghai Public Health Clinical Center), Yanmin Wan(Shanghai Medical College of Fudan University), Ariana Hirsh(Icahn School of Medicine at Mount Sinai), Xiaoyan Zhang(Fujian Medical University), Xiaolin Shi(Biotechnology Research Center), Shan Jin(Harvard University), Di Tian, Songhua Yuan(Shanghai Medical College of Fudan University), Raffael Nachbagauer(Moderna Therapeutics (United States)), Yunwen Hu(Southern University of Science and Technology), Xinci Xie(Shanghai Medical College of Fudan University)
The Journal of Immunology
May 1, 2017
10.4049/jimmunol.198.supp.125.18
Cited by 0

Related Papers

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
|Nature|2021|882
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713